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ABSTRACT 
Methionine adenosyltransferase (MAT) is an essential enzyme because it catalyzes the formation 
of S-adenosylmethionine (SAMe), the principal biological methyl donor. Of the two genes that 
encode MAT, MAT1A is mainly expressed in adult liver and MAT2A is expressed in all 
extrahepatic tissues. Mice lacking MAT1A have reduced hepatic SAMe content and 
spontaneously develop hepatocellular carcinoma. The current study examined the influence of 
chronic hepatic SAMe deficiency on liver regeneration. Despite having higher baseline hepatic 
staining for proliferating cell nuclear antigen, MAT1A knockout mice had impaired liver 
regeneration after partial hepatectomy (PH) as determined by bromodeoxyuridine incorporation. 
This can be explained by an inability to up-regulate cyclin D1 after PH in the knockout mice. 
Upstream signaling pathways involved in cyclin D1 activation include nuclear factor κB 
(NFκB), the c-Jun-N-terminal kinase (JNK), extracellular signal-regulated kinases (ERKs), and 
signal transducer and activator of transcription-3 (STAT-3). At baseline, JNK and ERK are more 
activated in the knockouts whereas NFκB and STAT-3 are similar to wild-type mice. Following 
PH, early activation of these pathways occurred, but although they remained increased in wild-
type mice, c-jun and ERK phosphorylation fell progressively in the knockouts. Hepatic SAMe 
levels fell progressively following PH in wild-type mice but remained unchanged in the 
knockouts. In culture, MAT1A knockout hepatocytes have higher baseline DNA synthesis but 
failed to respond to the mitogenic effect of hepatocyte growth factor. Taken together, our 
findings define a critical role for SAMe in ERK signaling and cyclin D1 regulation during 
regeneration and suggest chronic hepatic SAMe depletion results in loss of responsiveness to 
mitogenic signals. 
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ethionine is an essential amino acid metabolized mainly by the liver, where it is 
converted, by the enzyme methionine adenosyltransferase (MAT), into S-
adenosylmethionine (SAMe), the main biological methyl donor, precursor for 
polyamines and GSH (1). About 50% of methionine metabolism and up to 85% of all 
methylation reactions occur in the liver (2). In mammals, there are two genes encoding MAT 
isoenzymes: MAT I/III are gene products of MAT1A, and MAT II is the gene product of MAT2A. 
Whereas MAT1A is expressed mainly in the adult liver and is a marker for differentiated liver, 
MAT2A is expressed in all tissues, including fetal liver, hepatocellular carcinoma (HCC), and, in 
small quantities, in the adult liver (2). MAT2A is up-regulated during rapid liver growth and de-
differentiation (2). Due to differences in the regulatory and kinetic properties of the various 
MATs, MAT II cannot maintain the same high levels of SAMe as compared with the 
combination of MAT I and MAT III (2). Consequently, in MAT1A knockout mice, despite a 
significant increase in MAT2A expression, the liver content of SAMe is reduced about threefold 
from birth, when the switch from MAT2A and MAT1A normally takes place (3). 
It has long been realized that patients with cirrhosis often have hypermethioninemia and delayed 
plasma clearance of methionine after an i.v. injection (4). This is due to reduced hepatic MAT 
activity as a result of decreased MAT1A expression and inactivation of its gene products MAT 
I/III (5, 6). Thus, the biosynthesis of hepatic SAMe is impaired in cirrhotic patients, which can 
lead to reduced transmethylation and GSH synthesis (2). This may explain the finding that 
SAMe treatment of cirrhotic patients resulted in restoration of hepatic GSH levels (7). The 
MAT1A knockout mouse model exhibits abnormalities that mimic human cirrhotics, namely 
hypermethioninemia, chronic hepatic SAMe, and GSH deficiency (3), and serves as an excellent 
tool to examine the consequences of such deficiencies. 
Using the MAT1A knockout mouse model, we have described two major consequences of 
chronic hepatic SAMe deficiency. The first is the predisposition of these animals to develop liver 
injury either in response to a choline-deficient diet or carbon tetrachloride, or spontaneous 
development of steatohepatitis (3, 8). The second is abnormal hepatic growth, resulting in 
spontaneous development of HCC (3, 8). SAMe deficiency is a well-known consequence of diets 
deficient in lipotropes and may be the underlying mechanism of steatohepatitis and HCC 
development in rodents fed such diets (9). 
Accumulating evidence suggests SAMe is an important modulator of hepatocyte growth (2, 8, 
13, 14). Whereas chronic hepatic SAMe deficiency leads to malignant degeneration (8), a 
transient fall in hepatic SAMe level precedes liver regeneration after 2/3 partial hepatectomy 
(PH) (10) and is necessary for normal regeneration to occur (11, 12). The mechanism may lie in 
the ability of SAMe to inhibit the mitogenic effect of hepatocyte growth factor (HGF), which 
was demonstrated using cultured rat hepatocytes (13). In this experimental model, the mitogenic 
effect of HGF requires inducible nitric oxide synthase (iNOS), which is also induced after PH 
(14). Because MAT I/III can be inhibited by nitrosylation (2), one plausible scenario is that 
increased iNOS expression that occurs soon after PH leads to increased nitric oxide levels and 
inhibition of MAT I/III. This in turn results in lower hepatic SAMe levels and release of the 
inhibitory effect that this molecule exerts on the proliferative activity of HGF. This mechanism 
would not work in the MAT1A knockout mouse because MAT II is not subject to nitrosylation 
and inactivation (2). How the liver responds to PH in this setting is unknown and forms the 
subject of the current work. This has direct relevance to human liver disease because a 
M 
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significant proportion of cirrhotics have undetectable MAT1A expression, presumably due to 
hypermethylation of the MAT1A promoter (6). 
MATERIALS AND METHODS 
Partial hepatectomy experiments 
Two-third hepatectomy experiments were performed using 2- to 3-month-old male wild-type 
mice and MAT1A knockout mice (3). Mice were fed ad libitum a standard diet (Harland Teklad 
irradiated mouse diet 7912, Madison, WI) and housed in a temperature-controlled animal facility 
with 12 h light-dark cycles. Animals were treated humanely, and all procedures were in 
compliance with our institutions’ guidelines for the use of laboratory animals. Two-third PH was 
done according to the method of Higgins and Andersen (15) between 8 and 11 a.m. There was no 
operative mortality. Liver specimens removed represented time zero and were snap frozen in 
liquid nitrogen or formalin fixed for subsequent analysis as described below. Animals were 
allowed to recover for up to 72 h without postoperative mortality. Groups of animals (n=3–5 
each) were killed at 0.5 h, 24 h, 36 h, 48 h, and 72 h. Two h before they were killed, mice were 
injected i.p. with bromodeoxyuridine (BrdU, 100 mg/kg body weight) to assess hepatocyte DNA 
synthesis. For the groups that were killed at 0.5 h, animals received BrdU injection 2 h before 
PH. The liver resected at the time of PH from this group formed the baseline BrdU values. At the 
time of sacrifice, livers were weighed and rapidly split into several pieces, some were snap 
frozen for subsequent RNA or protein extraction; others were formalin fixed for histology and 
immunohistochemistry as described below. 
Liver histology and immunohistochemistry 
Sections from formalin-fixed and paraffin-embedded liver tissue were stained with mouse 
monoclonal anti-BrdU antibody (Sigma, St. Louis, MO), 1:1000 dilution, at 4°C overnight. 
Secondary antibody was peroxidase-labeled goat anti-mouse antibody (Dako Envision System 
Carpinteria, CA) incubated at room temperature for 30 min. Hepatic nuclear BrdU incorporation 
was evaluated by two observers blinded to the animal’s identity and treatment. BrdU 
incorporation was measured by the number of BrdU (+) nuclei in 10 microscope fields using a 
40× objective and a 10× eyepiece with a Nikon 400 microscope and Morphometric software. 
Proliferating cell nuclear antigen (PCNA) expression was evaluated in a similar manner, using 
mouse monoclonal anti-PCNA primary antibody, followed by peroxidase-labeled goat anti-
mouse antibody (Dako Envision System) at room temperature for 3 h, stained with peroxidase 
substrate (dab) 3,3′-diamino-benzidine chromagen (Dako) and counterstained with hematoxylin. 
PCNA expression was measured by the number of PCNA (+) nuclei in 10 microscope fields 
(×400) in each specimen. Finally, apoptosis was evaluated in these liver specimens using the 
TUNEL assay performed according to the manufacturer’s instructions (In Situ Cell Death 
Detection Kit; Boehringer Mannheim, Indianapolis, IN) and using the same morphometric 
analysis as above. 
Cell culture experiments 
Hepatocyte isolation and DNA synthesis were measured as previously described (14). 
Hepatocytes were isolated from 3-month-old MAT1A knockout and wild-type mice as previously 
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described (14). Cultures were maintained in MEM medium supplemented with 5% fetal bovine 
serum (FBS), nonessential amino acids, 2 mmol/l glutamine, and antibiotics (Gibco-BRL, 
Carlsbad, CA). Medium was changed, and in the absence of serum, DNA synthesis was 
measured in response to varying concentrations of HGF (6.25, 12.5, and 25 ng/ml) for 36 and 72 
h. A pulse of [3H]thymidine (1µ Ci/well) was started 28 h after HGF addition. Cells were 
harvested, and thymidine incorporation was determined in a scintillation counter. 
RNA isolation and gene expression analysis 
Total liver RNA was isolated by the guanidinium thiocyanate method. RNA concentration was 
determined spectrophotometrically before use, and the integrity was checked by electrophoresis 
with subsequent ethidium bromide staining. Electrophoresis of RNA, gel blotting, and Northern 
hybridization analysis were performed on total RNA using standard procedures as previously 
described (3). Specific MAT1A, MAT2A, and 18S rRNA probes were labeled with [32P]dCTP 
using a random primer kit (RediPrime DNA Labeling System; Amersham Pharmacia Biotech 
Piscataway, NJ) as previously described (3). Autoradiography and densitometry (Gel 
Documentation System, Scientific Technologies, Carlsbad, CA, and NIH Image 1.60 software 
program) were used to quantitate relative RNA. Results of Northern blot analysis were 
normalized to 18S rRNA. 
For genes with low levels of expression, reverse-transcription polymerase chain reaction (RT-
PCR) was used to assess their expression. These genes include iNOS, uncoupling protein 2 
(UCP2), tumor necrosis factor α (TNF-α), and interleukin 6 (IL-6). One microgram of total 
RNA was subjected to reverse transcription using Superscript II reverse transcriptase (Invitrogen, 
Carlsbad, CA) and oligo(dT) as the priming agent. After 1 h incubation at 43°C, the reactions 
were stopped by heating at 70°C for 15 min. Template RNA was then removed using RNase H 
(Invitrogen). Ten percent of the reverse transcriptase reaction was amplified using primers for iNOS (5′-
CAGGGAATCTTGGAGCGAGTTGTGG-3′ sense and 5′-CCCGTACCAGGCCCAATGAG GAT-3′ 
antisense, which corresponds to nucleotides 2406 to 3007 of the iNOS gene [16]), UCP2 (5′-
ACTTCTCCCAATGTTGCCCG-3′ sense and 5′-GACTGGGCAGAGGATGAAG -3′ antisense, which 
corresponds to nucleotides 897 to 1344 of the UCP2 gene [17]), TNF-α (18), and IL-6 (19). 18S 
rRNA was amplified simultaneously using QuantumRNA Classic II 18 s (Ambion, Austin, TX) 
for internal control of RNA loading. The PCR condition for iNOS was 38 cycles (94°C, 45 s; 
68°C, 45 s; 72°C, 45 s), for UCP2 was 38 cycles (94°C, 45 s; 60°C, 45 s; 72°C, 45 s), for TNF-α 
was 38 cycles (94°C, 45 s; 60°C, 45 s; 72°C, 1min), and for IL-6 was 41 cycles (94°C, 45 s; 
55°C, 1 min; 72°C, 1 min). Expression of these genes was normalized to 18S expression. 
Western blot analysis 
Liver homogenates were subjected to Western blot analysis as we previously described (3, 8, 
14). Equal amounts of protein (50 µg/well) were resolved in 12.5% SDS-polyacrylamide gels. 
Proteins were electrophoretically transferred to nitrocellulose membranes, blocked with tris-
buffered saline (pH 7.6)/0.1% Tween 20 containing 5% nonfat dried milk, washed with tris-
buffered saline/0.1% Tween 20, and incubated 1.5 h with primary antibodies in tris-buffered 
saline/0.1% Tween 20 containing 5% nonfat dried milk. Blots were washed in tris-buffered 
saline/0.1% Tween 20 and incubated 45 min with the secondary antibody in tris-buffered 
saline/0.1% Tween 20 containing 5% nonfat dried milk. Membranes were probed with anti-MAT 
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I/III, anti-cyclin D1 (Santa Cruz Biotechnology, Santa Cruz, CA) 1:100, anti-phospho-
extracellular signal-regulated kinase (ERK) (Cell Signaling Technology, Lexington, KY) 1:100, 
anti-ERK-2 1:500, anti-phospho signal transducer and activator or transcription-3 (STAT-3) 
1:100, anti-STAT-3 1:500, anti-phospho-c-jun 1:500, anti-c-jun 1:500, anti-p65 or p50 1:200 
antibodies (Santa Cruz Biotechnology). To ensure equal loading, we stained protein gels with 
Coomassie blue and/or stripped membranes and reprobed them with anti-actin antibodies (Santa 
Cruz Biotechnology). A horseradish peroxidase-conjugated secondary antibody was used. Blots 
were developed by enhanced chemoluminescence. 
Electrophoretic mobility shift assay (EMSA) and supershift assay 
Nuclear proteins were extracted from wild-type and knockout livers at time 0 and 24 h and 
subjected to EMSA for NFκB as previously described (20) using a consensus NFκB probe 
(Santa Cruz Biotechnology). Supershift analysis was done using anti-p50 antibodies as we 
previously described (20). 
Hepatic ATP levels 
Hepatic ATP levels were measured by luciferase assay using reagents from Sigma according to 
the manufacturer’s instructions. Before the assay was performed, snap frozen liver specimens (50 
mg/mouse) were pulverized in a mortar and pestle under liquid nitrogen, suspended in ice-cold 
lysis buffer, and centrifuged at 4°C for 5 min, and the supernatant was removed for measurement 
of luciferase activity using a TD-20/20 Luminometer (Promega, Madison, WI) at 37°C. ATP 
levels in the samples were determined by comparison with a concurrent standard curve and 
expressed as µg ATP/g liver. 
Hepatic SAMe levels 
Hepatic SAMe levels were measured using a method described previously (10) with slight 
modifications. Liver specimens were homogenized in phosphate-buffered saline, and an aliquot 
was saved for protein assay. The rest was treated with 100 µl of 1 M perchloric acid (PCA) on 
ice for 5 min and centrifuged at 1000g for 15 min at 4°. The aqueous layer was quantitatively 
removed, neutralized with 3 M KOH, and centrifuged at 3000g for 10 min at 4°C. SAMe levels 
were determined in the neutralized PCA extracts by HPLC (LC-10ATVP pump, SCL-10AVP 
system control, Shimadzu, Columbia MD) with a SPD-10AVP UV detector and a SIL-10ADVP 
autosampler (Shimadzu) using a Partisil SCX 10 µm column (25×0.44 cm i.d.; Whatman Chem. 
Sep. Maidstone, Cleveland, OH). SAMe was eluted isocratically at 1 ml/min with 0.19 M 
NH4H2PO4 adjusted to pH 2.6 with 2 M H3PO4. SAMe levels were calculated using standard 
curve of SAMe prepared at the same time as the samples and are reported as nmol/mg protein. 
Statistics  
Two-tailed non-paired Student’s t test was used for comparisons between two groups, ANOVA 
followed by Fisher’s test was used for comparison of more than two groups. Significance was 
defined by P < 0.05. 
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RESULTS 
Liver regeneration in the MAT1A knockout mice 
Liver regeneration was assessed in the knockout and wild-type mice by using PCNA staining and 
BrDU incorporation. PCNA is an auxillary protein of DNA polymerase delta. Its expression is 
cell cycle dependent, being first detected in late G1 and remains increased throughout the S phase 
and into the early postreplicative G2 period (21). BrDU is a thymidine analog that is incorporated 
into DNA during DNA synthesis (21). Thus, whereas both are markers of cellular replication, 
only BrDU is a specific marker for the S phase. Figure 1A shows that peak BrDU incorporation 
occurred at 48 h after PH in the wild-type and knockout mice. However, the number of BrDU-
positive hepatocytes was much lower in the knockout mice at both 48 and 72 h. Interestingly, 
although baseline hepatic PCNA staining was much higher in the knockout mice, it fell 
significantly after PH instead of increasing steadily as in the wild-type mice (Fig. 1B). Figure 2 
depicts these changes immunohistologically. The impairment in liver regeneration is not due to 
liver cell death as necrosis was not seen histologically and apoptosis was not detected on 
TUNEL assay (data not shown). 
MAT expression during liver regeneration 
We had previously shown that MAT1A expression falls transiently just before peak DNA 
synthesis whereas MAT2A is induced during liver regeneration in the rat (10). Others have shown 
that MAT2A up-regulation is required for proliferation to occur (22). Northern and Western blot 
analyses show that MAT1A expression remains elevated up to 72 h after PH in mice (Fig. 3). 
Hepatic MAT2A expression is induced at baseline in the knockout mice as we showed previously 
(3) and remains elevated up to 72 h after PH in both knockout and wild-type mice. (Fig. 3). 
Mechanism of impaired liver regeneration 
Immediately following PH, adult hepatocytes enter into a state of prereplicative competence 
before they can fully respond to growth factors. This priming step is thought to be mediated 
partly by an early release of TNF-α and IL-6, resulting in the activation of NFκB, c-Jun-N-
terminal kinase (JNK), and STAT-3 and entry in G1 phase (23, 24). These initiated cells are then 
able to further progress in early G1 phase but require growth factor stimulation to progress 
beyond the restriction point in mid to late G1 and enter S phase (23, 24). Although NFκB, JNK, 
and STAT-3 activation occur in early G1, cyclin D1 is a delayed-early gene that is induced at the 
G1-S boundary and required for progression from G1 to S phase (24, 25). We next examined 
whether the activation of these pathways may be impaired in the MAT1A knockout mice 
following PH. 
Figure 4 shows that TNF-α (Fig. 4A) and IL-6 (Fig. 4B) are induced in a similar manner in the 
knockouts as compared with wild-type mice. JNK activation as measured by level of 
phosphorylated c-jun is evident shortly after (30 min) PH in both wild-type and knockout mice 
(Fig. 5A). Note that the baseline level of phospho-c-jun is elevated in the knockout mice and 
although the level remains elevated in the wild-type mice, it fell progressively after this early 
increase in the knockout mice. By 36 h after PH, the level of phospho-c-jun was lower in the 
knockout as compared with wild-type mice (Fig. 5A). Changes in phospho-c-jun levels paralleled 
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changes in total c-jun levels (Fig. 5A). Similarly, NFκB activation as measured by the levels of 
p50 and p65 is also higher at baseline for the knockouts and increased shortly after PH (Fig. 5B 
and C). The level of p50 was not appreciably increased in the wild-type mice but was clearly 
induced in the knockouts at all time points examined after PH (Fig. 5B). The level of p65 
increased progressively following PH in the wild-type mice but peaked at 30 min after PH in the 
knockouts (Fig. 5C). However, NFκB nuclear binding activity appeared comparable between 
wild-type and knockout mice at baseline and both were induced at 24 h after PH (Fig. 5D). 
Consistent with intact NFκB signaling is the observation that iNOS, a NFκB target gene (16), is 
similarly induced in both knockouts and wild-type mice (Fig. 4C). STAT-3 is a known 
downstream target of IL-6 that is also critical for normal liver regeneration to occur (26). This 
pathway appears to be intact in the MAT1A knockout mice (Fig. 6A). 
JNK belongs to the family of stress-activated kinases and is one of multiple cellular signaling 
pathways activated shortly after PH (23, 27, 28). The other major signaling pathway activated is 
the mitogen-activated kinase (MAPK) pathway (23, 27, 28). ERKs are activated by 
phosphorylation, and two highly related MAPKs, p44 and p42, also called ERK1 and ERK2, are 
activated shortly after PH (24, 27, 17). Two peaks of ERK phosphorylation were observed after 
PH: one in early G1, within 1 h of PH, and one in mid-late G1, just preceding cyclin D1 mRNA 
induction (24). Figure 6B shows that ERKs are hyperphosphorylated at baseline in the knockout 
mice, and similar to the pattern observed with phospho-c-jun, the levels of phosphorylation 
decreased progressively in the knockout mice instead of increasing progressively as observed in 
the wild-type mice. At 36 h after PH before peak DNA synthesis, ERK phosphorylation was 
lower in the knockout as compared with wild-type mice (Fig. 6B). Total ERK2 levels were not 
different between knockout and wild-type mice and remained unchanged from baseline after PH 
(Fig. 6B). 
Cyclin D1 induction is required for the G1/S transition (23, 25, 28, 29). Upstream signaling 
pathways involved in cyclin D1 activation include NFκB, JNK, ERKs, and STAT-3 (29). Figure 
6C shows that although cyclin D1 expression is doubled at baseline in the knockout mice, it 
failed to increase significantly after PH as compared with the wild-type mice. Cyclin D1 protein 
levels in the knockout livers were 6%, 15%, and 33% of wild-type livers at 24, 36, and 48 h after 
PH, respectively (Fig. 6C). Early activation of JNK, STAT3, and NFκB, coupled with the 
inability of the MAT1A knockout hepatocytes to up-regulate cyclin D1, suggests these 
hepatocytes are arrested in the prereplicative (G1) phase of the cell cycle following PH. 
Another factor important for cyclin D1/cyclin-dependent kinase activity is cellular ATP levels 
because ATP binding is required to activate the complex (27). This is an important consideration 
because we have shown that MAT1A knockout mice exhibit impaired hepatic mitochondrial 
function and have elevated UCP2 expression (8, 30). We confirmed that UCP2 expression is 
more than doubled at baseline in the knockout mice (Fig. 4D). However, UCP2 mRNA levels 
remained constant during liver regeneration in the knockout mice in contrast to the induction that 
occurred in the wild-type mice (Fig. 4D). Baseline hepatic ATP levels tended to be lower in the 
knockout mice and failed to increase at 36 h after PH as observed in the wild-type mice (Fig. 7). 
To examine whether the impairment in regeneration may be due to loss of responsiveness to 
mitogenic signals, we isolated hepatocytes from wild-type and MAT1A knockout mice and 
measured DNA synthesis in response to varying concentrations of HGF. At baseline, knockout 
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hepatocytes had a 12.7-fold higher incorporation of thymidine than wild-type hepatocytes (wild 
type=1971±303, knockout=25,006±1281, expressed as mean±SD in unit of cpms/3×104 cells, 
P<0.01), which agrees with these cells being in a state of enhanced proliferation in the intact 
organ. Upon HGF treatment, wild-type hepatocytes showed a dose-dependent increase in 
thymidine incorporation into DNA (up to ~4.5-fold), whereas knockout hepatocytes had a 
minimal response (~1.5-fold) and showed no dose-dependency (Fig. 8). The response in the 
knockout hepatocytes was not merely delayed, because the same impaired effect of HGF on 
DNA synthesis was observed after 72 h of treatment (data not shown). 
We had previously shown that SAMe inhibits the mitogenic effect of HGF on hepatocytes by an 
iNOS-dependent mechanism (14). This, coupled with the observation that hepatic SAMe levels 
fall after PH but before peak DNA synthesis (10), led us to speculate that the fall in SAMe may 
be due to NO-mediated inactivation of MAT I/III, which then releases the inhibitory tone of 
SAMe on HGF (14). This mechanism would not work in MAT1A knockout mice because MAT 
II is not subject to inactivation by NO (2). To examine this, we measured hepatic SAMe levels at 
various times after PH. In the wild-type animals, SAMe levels fell progressively from 24 to 48 h 
whereas they remained essentially unchanged in the knockout mice (Table 1). 
DISCUSSION 
Adult hepatocytes are normally quiescent (in G0 phase) but retain enormous proliferative 
capacity when a deficit in hepatic mass occurs, such as following PH (23). Much has been 
learned about the mechanisms by which liver regeneration occurs, but there remains large gaps 
in many fundamental areas. One area addressed here is the effect of chronic hepatic SAMe 
deficiency on liver regeneration. This is a clinically relevant problem because cirrhotic patients 
have impaired hepatic SAMe biosynthesis due to decreased MAT1A expression and inactivation 
of MAT I/III (2, 6). Many cirrhotic patients have undetectable MAT1A expression, presumably 
due to promoter hypermethylation (6). The MAT1A knockout mouse model exhibits chronic 
hepatic SAMe deficiency (3) and represents an ideal model to address this question. 
We have previously shown that in rodents, an early event after PH that precedes DNA synthesis 
is a transient fall in hepatic SAMe level (10). This could be partly attributed to an induction in 
the expression of MAT2A, which along with the fall in SAMe, has been shown by others to be 
necessary for hepatocyte proliferation to occur (10–12, 22). A potential mechanism for this is the 
ability of SAMe to modulate the activity of HGF. We have shown that SAMe inhibits the 
mitogenic effect of HGF, an effect that required iNOS (14). We hypothesized that following PH, 
the increase in nitric oxide production leads to inhibition of MAT I/III, leading to a fall in hepatic 
SAMe and release of the inhibitory tone this molecule exerts on the mitogenic activity of HGF 
(2, 14). However, this mechanism would not work in the MAT1A knockout mouse because MAT 
II is not subject to inactivation by nitric oxide (2). However, MAT1A knockout mice exhibit 
enhanced hepatic growth and develop spontaneous HCC (3, 8). How they respond to PH is of 
interest and the subject of current work. 
MAT1A knockout mice exhibited an impaired regenerative response following PH. This is 
documented by a nearly 2/3 reduction in the number of BrDU positive hepatocytes at the time of 
peak DNA synthesis. There are two critical steps in liver regeneration: the transition of the 
quiescent hepatocyte into the cell cycle (priming) and the progression beyond the restriction 
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point in the G1 phase of the cell cycle (23). Priming is believed to be largely attributed to TNF-α 
and IL-6, which then activate several signal transduction pathways, including NFκB, JNK, and 
STAT-3 in early G1 phase (23, 24). Each of these pathways has been shown to be essential for 
liver regeneration to occur (23, 26, 28). Whereas priming is largely under the control of 
cytokines, progression in the G1 phase and beyond the restriction point is believed to be 
controlled by growth factors such as HGF and transforming growth factor α (TGF-α) as well as 
cyclin D1 (23). Our data indicate that the early priming events appear to be intact in the knockout 
mice. Both TNF-α and IL-6 response are similar in the knockouts as compared with wild-type 
mice. This is consistent with early induction of NFκB, c-jun, and STAT-3. MAT2A and iNOS, 
two genes that have been shown to be essential for liver regeneration (22, 23), are also similarly 
induced in both types of mice. Intact iNOS response also suggests that NFκB signaling is not 
impaired in the knockout mice. 
Our data indicate that there is a defect in the progression in G1 phase in the MAT1A knockout 
hepatocytes and possibly a defect in response to growth factors. A critical factor in G1 
progression and up-regulation of cyclin D1 in mid-late G1 phase is activation of ERK1/2 (24). 
We found ERK1/2 to be hyperphosphorylated and cyclin D1 expression higher in the knockout 
mice at baseline, consistent with an enhanced growth phenotype of these cells, as we previously 
reported (3, 8). However, following PH, ERK1/2 phosphorylation fell in the knockout mice and 
cyclin D1 failed to increase. This is consistent with arrest of the MAT1A knockout hepatocytes in 
the G1 phase of the cell cycle. Interestingly, although acute MAPK cascade activation promotes 
G1 progression and S phase entry, chronic activation of the MAPK cascade actually inhibits this 
process (32). Our data are consistent with this observation. JNK is also required for cyclin D1 
expression (28). In the knockout mice, baseline JNK activity is enhanced, and although it 
increased shortly after PH, the increase was short-lived and, by 36 h after PH, it was lower than 
in wild-type mice. The reason for the inability to sustain JNK activation in the knockout mice is 
not clear, and it is also unclear whether this would have an impact on the course of regeneration. 
Another factor important for G1 progression is ATP store (27). Hepatic ATP levels did not 
increase in the MAT1A knockout mice following PH, which is likely due to known impairment in 
hepatic mitochondrial function of these animals (30). It is possible that this also contributed to 
the impairment in G1 progression. The mechanism of the blunted ATP response in the knockout 
mice is likely to be multifactorial. Both UCP-dependent and independent mechanisms are likely 
to be involved. 
To investigate whether MAT1A hepatocytes have abnormal responsiveness to mitogenic signals, 
we used the cultured hepatocyte model to directly test the mitogenic effect of HGF. MAT1A 
hepatocytes have higher baseline DNA synthesis, which is consistent with a heightened 
proliferative state observed in vivo. However, little to no increase in DNA synthesis occurred in 
response to increasing doses of HGF, supporting the notion that one key abnormality in these 
hepatocytes is a loss in responsiveness to mitogens. 
To test our hypothesis that loss of responsiveness to HGF may be due to the inability of NO to 
down-regulate MAT II in the MAT1A knockout mouse livers, we next measured hepatic SAMe 
levels. Consistent with this hypothesis, although hepatic SAMe levels fell progressively from 24 
to 48 h in the wild-type animals, they remained essentially unchanged in the knockout livers. 
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Our findings are reminiscent of the impaired liver regeneration reported in ob/ob mice (27). Both 
MAT1A knockout mice and ob/ob mice have impaired cyclin D1 response following PH, and the 
hepatocytes are arrested in G1. However, in the ob/ob mice, JNK and NFκB activation are 
impaired while ERK1/2 are superinduced (27). Thus, different mechanisms are responsible for 
the impaired cyclin D1 response. There are also similarities in our findings to those of the c-myc 
and TGF-α double transgenic mice (33). The double transgenic mice exhibit severe liver cell 
dysplasia and develop spontaneous liver neoplasms (33). Interestingly, the capacity of the 
transgenic livers to regenerate was markedly impaired following postnatal liver growth, which 
suggests early replicative senescence (33). The authors hypothesized that in these double 
transgenic mice, two alternative outcomes can occur with regard to growth potential: either an 
early loss of proliferative activity and eventual death or escape from a senescent pathway and 
rapid progression to an immortal tumor phenotype (33). A universal characteristic of senescent 
cells is the inability to respond to mitogenic signals (33). Given that the MAT1A knockout mice 
are predisposed to HCC and are unable to respond to mitogenic signals, the possibility of 
replicative senescence is real and deserves further study. 
In summary, MAT1A knockout mice exhibit impairment in liver regeneration following PH. 
While the initial priming event appears to be intact, there is a defect in the progression in G1 
phase. This is due largely to the inability of cyclin D1 up-regulation, which may be related to the 
chronic activation of ERK1/2 and loss of response to growth factors possibly related to lack of a 
significant fall in hepatic SAMe levels. These findings have direct relevance to human liver 
cirrhosis where MAT1A is often silenced and hepatic SAMe store is depleted. 
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Table 1 
 
Hepatic SAMe levels during liver regenerationa 
 
Time after 2/3 PH                    SAMe level (nmol/mg protein)    
 WT  KO 
  24 h 0.95±0.07 0.70±0.09 
  36 h 0.62±0.05b 0.75±0.06 
  48 h 0.53±0.03b 0.61±0.06 
     
aResults represent mean ± SE from three regenerating livers from wild-type (WT) and knockout (KO) animals for each time point. Hepatic SAMe 
levels were determined as described in Materials and Methods.   
bP < 0.05 vs. WT at 24 h by ANOVA followed by Fisher’s test. 
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Fig. 1 
 
                                  
 
Figure 1. Hepatocyte replication after PH as assessed by BrDU incorporation (A) or PCNA staining (B). Mice were 
injected with BrDU intraperitoneally 2 h before sacrifice as described in Materials and Methods. BrDU and PCNA 
immunohistochemistry and morphometric analysis were done as described in Materials and Methods using formalin-fixed 
and paraffin-embedded liver tissues. Results are expressed as mean ± SE from three to six wild-type (WT) and knockout 
(KO) mice at each time point. *P < 0.05 vs. WT. 
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Fig. 2 
 
                                             
Figure 2. Representative immunohistology from wild-type (WT) and knockout (KO) mice. Note the intense PCNA 
staining at 0 h in the KO, which decreased at 48 h. In contrast, baseline PCNA expression is minimal in the WT, but many 
mitotic figures are seen at 48 h (arrows). BrDU incorporation (brown color stained nuclei) is nil at baseline in both types 
of mice and is much lower in the KO at 48 h. Hematoxylin and eosin ×400. 
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Fig. 3 
 
                               
                      
Figure 3. Northern (A) and Western blot (B) analysis of hepatic MAT during liver regeneration in the MAT1A 
knockout (–/–) and wild-type mice. Mice underwent 2/3 PH and were sacrificed at various times (0.5–72 h). Liver 
removed at the time of PH was used for baseline (0 time). Northern blot analysis was done using specific MAT1A and 
MAT2A cDNA probes as described in Materials and Methods. Membranes were sequentially probed with MAT1A, 
MAT2A, and 18S rRNA. Representative blots are shown. Western blot analysis was done using anti-MAT I/III antibodies 
using 50 µg liver homogenates from various time points (0–72 h). Representative blots are shown. 
Page 17 of 22
(page number not for citation purposes)
Fig. 4 
 
                                       
                      
Figure 4. RT-PCR of TNF-α, IL-6, iNOS, and UCP2 in livers of MAT1A knockout (–/–) and wild-type mice.  Mice 
were sacrificed at various times (0.5–72 h) following PH as described in Materials and Methods. Liver removed at the 
time of PH was used for baseline (0 time). Representative RT-PCRs are shown. Densitometric changes are shown in the 
right panels, expressed as the ratio of the gene of interest over 18S. *P < 0.05 vs. wild type at time 0. 
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Fig. 5 
 
                      
                                          
Figure 5. Western blot analysis of phospho-c-jun (P-c-jun), total c-jun (A), p50 (B), and p65 (C) in livers of 
MAT1A knockout (KO) and wild type (WT) mice. Mice were sacrificed at various times (0.5–36 h) following PH as 
described in Materials and Methods. Liver removed at the time of PH was used for baseline (0 time). Representative 
Western blots are shown. Densitometric changes are shown in the right panels, expressed as % of WT value at 0 h. EMSA 
with supershift analysis of NFκB nuclear binding activity in two WT and two KO mice at baseline and 24 h after PH was 
performed as described in Materials and Methods using 10 µg of nuclear protein each (D). *P < 0.05 vs. WT at time 0, †P 
< 0.05 vs. WT at respective time points. Page 19 of 22
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Fig. 6 
 
         
                      
Figure 6. Western blot analysis of phospho-STAT-3 (P-STAT-3), total STAT-3, phospho-ERK1/2 (P-ERK1/2), 
total ERK2, and cyclin D1 in livers of MAT1A knockout (KO) and wild-type (WT) mice. Mice were sacrificed at 
various times (0.5–36 h for P-STAT-3 and P-ERK1/2, 0–48 h for cyclin D1) following PH as described in Materials and 
Methods. Liver removed at the time of PH was used for baseline (0 time). Representative Western blots are shown. 
Densitometric changes are shown in the right panels, expressed as % of WT value at 0 h. *P < 0.05 vs. WT at time 0, †P < 
0.05 vs. WT at respective time points. Page 20 of 22
(page number not for citation purposes)
Fig. 7 
 
         
Figure 7. Changes in ATP content in livers of MAT1A knockout (KO) and wild-type (WT) mice. Mice were 
sacrificed at various times (24, 36, 48, and 72 h) following PH. Hepatic ATP levels were measured as described in 
Materials and Methods. Liver removed at the time of PH was used for baseline (0 time). Results are expressed as mean ± 
SE from three WT and three KO mice at each time point. *P < 0.05 vs. WT. 
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Fig. 8 
 
         
Figure 8. DNA synthesis in MAT1A knockout (KO) and wild-type (WT) hepatocytes in response to HGF. 
Hepatocytes were isolated from 3-month-old KO and WT animals and cultured as described in Materials and Methods. 
DNA synthesis was measured after treatment with varying concentrations of HGF. Results are expressed as mean ± SD 
from triplicates. Values found in either WT or KO control hepatocytes (HGF untreated cells) were arbitrarily given the 
value of one. *P < 0.05  vs.  WT control hepatocytes, **P < 0.05 vs. KO control hepatocytes and WT hepatocytes at 
respective HGF doses, †P <0.05 vs. WT treated with HGF 6.25 ng/ml, ††P < 0.05 vs. WT treated with HGF 12.5 ng/ml. 
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